European Society for Medical Oncology Clinical Practice Guidelines Recommend Scalp Cooling to Prevent Chemotherapy-Induced Alopecia

Richard Paxman, CEO of Paxman, commented: "Clinical Practice Guidelines effectively determine standards of care around the world and this adoption by the European Society for Medical Oncology will work towards a positive change in the supportive cancer care landscape. Paxman is the scalp cooling provider for many leading cancer centers throughout Europe and this update will serve to the continuation of our international mission in eliminating hair loss from chemotherapy and thus change the face of cancer."